Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
Sales | 2 | 14 | 80 | 104 | 107 |
Gross Profit | 2 | 14 | 80 | 104 | 107 |
Operating Expenses | 15,546 | 13,790 | 13,967 | 14,314 | 20,015 |
Operating Income | -15,544 | -13,776 | -13,887 | -14,210 | -19,908 |
Interest Expense | 2,680 | 2,685 | 2,773 | 2,772 | 2,760 |
Other Income | 783 | 3,251 | 1,944 | 10,148 | 8,178 |
Pre-tax Income | -17,441 | -13,210 | -14,716 | -6,834 | -14,490 |
Income Tax | N/A | 259 | 158 | -837 | N/A |
Net Income Continuous | -17,441 | -13,469 | -14,874 | -5,997 | -14,490 |
Net Income Discontinuous | N/A | -253 | 9,760 | 484 | 682 |
Net Income | $-17,441 | $-13,722 | $-5,114 | $-5,513 | $-13,808 |
EPS Basic Total Ops | -1.59 | -1.69 | -0.68 | -0.75 | -1.88 |
EPS Basic Continuous Ops | -1.59 | -1.63 | -1.99 | -0.81 | -1.97 |
EPS Basic Discontinuous Ops | N/A | -0.06 | 1.31 | 0.06 | 0.09 |
EPS Diluted Total Ops | -1.59 | -1.69 | -0.68 | -0.75 | -1.88 |
EPS Diluted Continuous Ops | -1.59 | -1.63 | -1.99 | -0.81 | -1.97 |
EPS Diluted Discontinuous Ops | N/A | -0.06 | 1.31 | 0.06 | 0.09 |
EPS Diluted Before Non-Recurring Items | -1.59 | -1.61 | -2.00 | N/A | N/A |
EBITDA(a) | $-15,023 | $-13,251 | $-13,327 | $-13,634 | $-19,243 |